Preview

International Journal of Veterinary Medicine

Advanced search

The use of corneal collagen cross-linking for the treatment of keratolysis in horses

Abstract

Keratolysis - is corneal tissue damage with stroma meltdown, caused by combined exposure to toxins released by microorganisms and MMP[1,2]. Treatment of keratomalacia involves the use of antibiotics, inhibition of proteolysis, and prevention or elimination of anterior uveitis. Antibiotic treatment of equine cornea with keratolysis can lead to acquired antibiotic resistance and selective propagation of resistant bacteria [3, 4]. The objects of the study were 10 horses with keratolysis, located in Moscow, and the Moscow, regione horse stables. The horses were divided into 2 groups, consisting of five animals. First group of patients were given the traditional treatment protocol, second group of horses were given crosslinking. For diagnosis, we used a Heine binocular lamp, a Schwabe,s slit lamp, and a fluorescein. Analysis of the results of treatment of first group: healing active neovascularization, and a dense scar was formed, second group horses: healing epithelization and translucent opacity was formed of a of 5±1 mm size. First group treatment was 45±2 days, second group treatment was 21±2 days. Well, crosslinking in horse reduces the treatment time, provides healing by the epithelization with the conservation of corneal transparency behind to the antibacterial effect, inhibition of proteolysis, and compaction of its tissue.

About the Authors

A. V. Goncharova
Moscow state Academy of veterinary medicine and bio-technology-MBA named after K. I. Scriabin
Russian Federation


L. F. Sotnikova
Moscow state Academy of veterinary medicine and bio-technology-MBA named after K. I. Scriabin
Russian Federation


E. N. Iomdina
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation


References

1. Brooks DE, Matthews AG. In: Veterinary ophthalmology. Volume II. 4. Gelatt KN, editor. Ames, IA, USA: Blackwell Publishing Professional; 2007. Equine ophthalmology; pp. 1192-1211.

2. Clode AC, Matthews AG. In: Equine ophthalmology. 2. Gilger BC, editor. Maryland Heights, MO, USA: Elsevier Saunders; 2011. Diseases and surgery of the cornea; pp. 181-215.

3. Moore CP, Collins BK, Fales WH. Antibacterial susceptibility patterns for microbial isolates associated with infectious keratitis in horses - 63 cases (19861994) J Am Vet Med Assoc. 1995;207 (7):928-933.

4. Пименов Н.В. Бактериофагия как основа для решения глобальной проблемы антибиотикорезистентности патогенных бактерий / Ветеринария, зоотехния и биотехнология. - 2020, №1. - С. 30-35.

5. Cannon DJ, Davison PF. Aging, and crosslinking in mammalian collagen. Exp Aging Res. 1977;3(2):87-105.

6. Baier J, Maisch T, Maier M, Engel E, Landthaler M, Baumler W. Singlet oxygen generation by UVA light exposure of endogenous photosensitizers. Biophys J. 2006;91(4):1452-1459.

7. McCall AS, Kraft S, Edelhauser HF, Kidder GW, Lundquist RR, Bradshaw HE, Dedeic Z, Dionne MJC, Clement EM, Conrad GW. Mechanisms of corneal tissue cross-linking in response to treatment with topical riboflavin and long-wavelength ultraviolet radiation (UVA) Invest Ophthalmol Vis Sci. 2010; 51(1): 129-138

8. Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion.Curr Eye Res. 2004;29(1):35-40.

9. Kohlhaas M, Spoerl E, Schilde T, Unger G, Wittig C, Pillunat LE. Biomechanical evidence of the distribution of cross-links in corneastreated with riboflavin and ultraviolet A light. J Cat Ref Surg.2006;32(2):279-283.

10. Иомдина, Е.Н. Биохимические аспекты кераторефракционной хирургии и корнеального кросслинкинга / Е.Н. Иомдина// Российская педиатрическая офтальмология. - 2015. - №4. - С. 3235.

11. Hellander-Edman A, Makdoumi K, Mortensen J, Ekesten B. Corneal cross-linking in 9 horses with ulcerative keratitis. BMC Vet Res. 2013 Jun 26; 9:128.

12. Иомдина, Е. Н. Применение ультрафиолетового корнеального кросслинкинга при язвах роговицы и других кератопатиях у животных /Е. Н. Иомдина, Л. Ф. Сотникова, А. В. Гончарова, Е. И. Кабанова, А. В. Чечнева, Н. Ю. Сапего, Е. В. Яни// Российский офтальмологический журнал. - 2019. - Том 12 №3. - С. 51-57.

13. Гончарова, А.В. Применение двухэтапной схемы лечения лошадей с кератолизисом, обеспечивающей эффективное ингибирование протеолиза роговицы /А.В. Гончарова, Л.Ф. Сотникова// Вестник Алтайского ГАУ. - 2020. - №3 (185). - С. 107-112.

14. Berman MB. Collagenase inhibitors: rationale for their Use in treating corneal ulceration. Int Ophthalmol Clin. 1975 ;15 (4):49-66.

15. Заявка на полезную модель № 2020118884 от 01.06.2020, положительное решение о выдаче патента от 11.08.2020 (авторы: Иомдина Е.Н., Ханджян А.Т., Яни Е.В., Голикова В. A., Сотникова Л. Ф., Гончарова А. B., Кирюхин А.В. Бровкин А.А.)

16. Гончарова, А.В. Патоморфологические изменения роговицы при кератолизисе у лошадей /А.В. Гончарова, Л.Ф. Сотникова// Вестник Алтайского ГАУ. - 2020. - №2 (184). - С. 78-84.


Review

For citations:


Goncharova A.V., Sotnikova L.F., Iomdina E.N. The use of corneal collagen cross-linking for the treatment of keratolysis in horses. International Journal of Veterinary Medicine. 2020;(3):176-182. (In Russ.)

Views: 255


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2072-2419 (Print)